Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

MLA

Achhra, A. C., et al. “Kidney Disease in Antiretroviral-Naïve HIV-Positive Adults with High CD4 Counts: Prevalence and Predictors of Kidney Disease at Enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Trial.” HIV Medicine, vol. 16 Suppl 1, Apr. 2015, pp. 55–63. EBSCOhost, https://doi.org/10.1111/hiv.12234.

APA

Achhra, A. C., Mocroft, A., Ross, M. J., Ryom, L., Lucas, G. M., Furrer, H., Neuhaus, J., Somboonwit, C., Kelly, M., Gatell, J. M., & Wyatt, C. M. (2015). Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine, 16 Suppl 1, 55–63. https://doi.org/10.1111/hiv.12234

Chicago

Achhra, A C, A Mocroft, M J Ross, L Ryom, G M Lucas, H Furrer, J Neuhaus, et al. 2015. “Kidney Disease in Antiretroviral-Naïve HIV-Positive Adults with High CD4 Counts: Prevalence and Predictors of Kidney Disease at Enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Trial.” HIV Medicine 16 Suppl 1 (April): 55–63. doi:10.1111/hiv.12234.